Literature DB >> 23463151

Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects.

Peter Zwanzger1, Maxim Zavorotnyy, Elena Gencheva, Julia Diemer, Harald Kugel, Walter Heindel, Tillmann Ruland, Patricia Ohrmann, Volker Arolt, Katharina Domschke, Bettina Pfleiderer.   

Abstract

According to preclinical studies, glutamate has been implicated in the pathogenesis of anxiety. In order to elucidate the role of glutamate in anxiety and panic in humans, brain glutamate+glutamine (Glx) levels were measured during cholecystokinin-tetrapeptide (CCK-4)-induced panic using magnetic resonance spectroscopy (MRS). Eighteen healthy subjects underwent a CCK-4 challenge. MR spectra were obtained from the anterior cingulate cortex (ACC) using a single voxel point-resolved spectroscopy method and analyzed using LCModel. A combined fitting of Glx was performed. Panic was assessed using the Acute Panic Inventory (API) and Panic Symptom Scale (PSS) scores. Moreover, hypothalamic-pituitary-adrenal axis stimulation was monitored throughout the challenge. There was a significant panic response following CCK-4 as revealed by a marked increase in both the panic scores (API: F(1,17)=149.41; p<0.0001; PSS: F(1,17)=88.03; p<0.0001) and heart rate (HR: F(1,17)=72.79; p<0.0001). MRS measures showed a significant increase of brain Glx/creatine (Glx/Cr) levels peaking at 2-10 min after challenge (F(1,17)=15.94; p=0.001). There was also a significant increase in CCK-4-related cortisol release (F(6,11)=8.68; p=0.002). Finally, significant positive correlations were found between baseline Glx/Cr and both APImax (r=0.598; p=0.009) and maximum heart rate (HR(max)) during challenge (r=0.519; p=0.027). Our results suggest that CCK-4-induced panic is accompanied by a significant glutamate increase in the bilateral ACC. The results add to the hypothesis of a disturbance of the inhibitory-excitatory equilibrium and suggest that apart from static alterations rapid and dynamic neurochemical changes might also be relevant for the neural control of panic attacks.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23463151      PMCID: PMC3717541          DOI: 10.1038/npp.2013.61

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  56 in total

1.  Vigorous exercise increases brain lactate and Glx (glutamate+glutamine): a dynamic 1H-MRS study.

Authors:  Richard J Maddock; Gretchen A Casazza; Michael H Buonocore; Costin Tanase
Journal:  Neuroimage       Date:  2011-05-27       Impact factor: 6.556

Review 2.  New perspectives in glutamate and anxiety.

Authors:  Carlos Riaza Bermudo-Soriano; M Mercedes Perez-Rodriguez; Concepcion Vaquero-Lorenzo; Enrique Baca-Garcia
Journal:  Pharmacol Biochem Behav       Date:  2011-04-30       Impact factor: 3.533

3.  Anterior cingulate proton spectroscopy glutamate levels differ as a function of smoking cessation outcome.

Authors:  Yasmin Mashhoon; Amy C Janes; J Eric Jensen; Andrew P Prescot; Gladys Pachas; Perry F Renshaw; Maurizio Fava; A Eden Evins; Marc J Kaufman
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-05-15       Impact factor: 5.067

Review 4.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.

Authors:  Rainer Rupprecht; Vassilios Papadopoulos; Gerhard Rammes; Thomas C Baghai; Jinjiang Fan; Nagaraju Akula; Ghislaine Groyer; David Adams; Michael Schumacher
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

Review 5.  Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.

Authors:  P Zwanzger; K Domschke; J Bradwejn
Journal:  Depress Anxiety       Date:  2012-05-02       Impact factor: 6.505

Review 6.  The use of cognitive enhancers in animal models of fear extinction.

Authors:  Gary B Kaplan; Katherine A Moore
Journal:  Pharmacol Biochem Behav       Date:  2011-01-20       Impact factor: 3.533

7.  Correlation of glutamate levels in the anterior cingulate cortex with self-reported impulsivity in patients with borderline personality disorder and healthy controls.

Authors:  Mareen Hoerst; Wolfgang Weber-Fahr; Nuran Tunc-Skarka; Matthias Ruf; Martin Bohus; Christian Schmahl; Gabriele Ende
Journal:  Arch Gen Psychiatry       Date:  2010-07-05

8.  Effect of acute psychological stress on prefrontal GABA concentration determined by proton magnetic resonance spectroscopy.

Authors:  Gregor Hasler; Jan Willem van der Veen; Christian Grillon; Wayne C Drevets; Jun Shen
Journal:  Am J Psychiatry       Date:  2010-07-15       Impact factor: 18.112

9.  Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.

Authors:  J C Ballenger; G D Burrows; R L DuPont; I M Lesser; R Noyes; J C Pecknold; A Rifkin; R P Swinson
Journal:  Arch Gen Psychiatry       Date:  1988-05

Review 10.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders.

Authors:  Caroline Nothdurfter; Thomas C Baghai; Cornelius Schüle; Rainer Rupprecht
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-08-26       Impact factor: 5.270

View more
  16 in total

1.  Imaging Mass Spectrometric Analysis of Neurotransmitters: A Review.

Authors:  Gustavo A Romero-Perez; Shiro Takei; Ikuko Yao
Journal:  Mass Spectrom (Tokyo)       Date:  2015-03-07

2.  Glutamate changes in anterior cingulate cortex following CCK-4 infusion.

Authors:  Richard J Maddock
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

3.  'Acute shift in glutamate-concentrations following experimentally induced panic with cholecystokinin-tetrapeptide-a 3T-MRS study in healthy subjects'-a reply to the letter to the editor.

Authors:  Peter Zwanzger; Alexander Yassouridis; Bettina Pfleiderer
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

4.  Psychostimulant drug effects on glutamate, Glx, and creatine in the anterior cingulate cortex and subjective response in healthy humans.

Authors:  Tara L White; Mollie A Monnig; Edward G Walsh; Adam Z Nitenson; Ashley D Harris; Ronald A Cohen; Eric C Porges; Adam J Woods; Damon G Lamb; Chelsea A Boyd; Sinda Fekir
Journal:  Neuropsychopharmacology       Date:  2018-03-06       Impact factor: 7.853

5.  Smaller volume of right hippocampal CA2/3 in patients with panic disorder.

Authors:  Masao Takaishi; Takeshi Asami; Haruhisa Yoshida; Ryota Nakamura; Asuka Yoshimi; Yoshio Hirayasu
Journal:  Brain Imaging Behav       Date:  2021-02       Impact factor: 3.978

Review 6.  Glutamate and dopamine in schizophrenia: an update for the 21st century.

Authors:  Oliver Howes; Rob McCutcheon; James Stone
Journal:  J Psychopharmacol       Date:  2015-01-13       Impact factor: 4.153

7.  Functional neuroanatomy in panic disorder: Status quo of the research.

Authors:  Thomas Sobanski; Gerd Wagner
Journal:  World J Psychiatry       Date:  2017-03-22

8.  Are working memory and glutamate concentrations involved in early-life stress and severity of psychosis?

Authors:  Mark Corcoran; Emma L Hawkins; Denis O'Hora; Heather C Whalley; Jeremy Hall; Stephen M Lawrie; Maria R Dauvermann
Journal:  Brain Behav       Date:  2020-05-09       Impact factor: 2.708

9.  Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study.

Authors:  Thomas Meyer; Mira-Lynn Chavanon; Christoph Herrrmann-Lingen; Maren Roggenthien; Kathleen Nolte; Burkert Pieske; Rolf Wachter; Frank Edelmann
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

10.  Acute stress effects on GABA and glutamate levels in the prefrontal cortex: A 7T 1H magnetic resonance spectroscopy study.

Authors:  L C Houtepen; R R Schür; J P Wijnen; V O Boer; M P M Boks; R S Kahn; M Joëls; D W Klomp; C H Vinkers
Journal:  Neuroimage Clin       Date:  2017-01-04       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.